Your session is about to expire
← Back to Search
Medication-Assisted Therapies for Opioid Use Disorder (ExMAT CA Trial)
N/A
Recruiting
Led By Frederick L Altice, MD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 36 months
Awards & highlights
Summary
This trial will study the best way to rapidly scale-up opioid agonist therapies in Central Asia to prevent HIV infections in people who inject drugs and their partners.
Who is the study for?
This trial is for adults with opioid dependence in Central Asia, specifically those who inject drugs and are either new to opioid agonist therapy (OAT) or have been on OAT for less than 90 days. It includes both individuals seeking treatment and professionals involved in delivering OAT.Check my eligibility
What is being tested?
The study tests the NIATx strategy, aiming to expand OAT programs effectively across Kazakhstan, Kyrgyzstan, and Tajikistan. The goal is to prevent HIV among people who inject drugs by improving addiction treatments using the EPIS framework.See study design
What are the potential side effects?
Since this trial focuses on implementing a treatment strategy rather than a specific medication, it does not directly involve medical side effects. However, participants may experience various reactions based on their individual responses to OAT.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 36 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~36 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
OAT Census
OAT Census per Oblast
Secondary outcome measures
Dropout
Dropout per Oblast
New Patients
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: NIATx ModelExperimental Treatment1 Intervention
Receiving NIATx Coaching
Find a Location
Who is running the clinical trial?
Yale UniversityLead Sponsor
1,874 Previous Clinical Trials
2,952,656 Total Patients Enrolled
AIDS Foundation East-West (AFEW) KyrgyzstanUNKNOWN
Institute for International Health and EducationUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- The study involves a survey that asks questions about injection drug use.I am over 18 and authorized to work at an opioid treatment program.I am 18 or older with opioid dependence, new to treatment or on treatment for less than 90 days.I am over 18 and a Chief Narcologist at an Oblast level.I am 18 years old or older.I am over 18 and work in opioid addiction treatment.I am over 18 and work in opioid addiction treatment.I am 18 or older, have opioid dependence, and am new to or have been on opioid addiction treatment for less than 90 days.I am 18 or older, have opioid dependence, and have never been on OAT or haven't been for over a year.The study is specifically looking for people who inject drugs and are receiving opioid agonist therapy.You meet the criteria for opioid addiction as defined in the DSM-V.This screening is only for people who inject drugs and are not currently on opioid agonist therapy.You have been diagnosed with an addiction to opioid drugs according to the DSM-V criteria.
Research Study Groups:
This trial has the following groups:- Group 1: NIATx Model
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger